miR-486 attenuates cardiac ischemia/reperfusion injury and mediates the beneficial effect of exercise for myocardial protection

被引:56
|
作者
Bei, Yihua [1 ,2 ]
Lu, Dongchao [3 ,4 ]
Baer, Christian [3 ,4 ]
Chatterjee, Shambhabi [3 ]
Costa, Alessia [3 ,4 ]
Riedel, Isabelle [3 ]
Mooren, Frank C. [5 ]
Zhu, Yujiao [1 ,2 ]
Huang, Zhenzhen [1 ,2 ]
Wei, Meng [1 ,2 ]
Hu, Meiyu [1 ,2 ]
Liu, Sunyi [6 ]
Yu, Pujiao [6 ]
Wang, Kun [7 ]
Thum, Thomas [3 ,4 ,8 ]
Xiao, Junjie [1 ,2 ]
机构
[1] Shanghai Univ, Peoples Hosp Nantong 6, Cardiac Regenerat & Ageing Lab, Affiliated Nantong Hosp,Sch Med,Inst Geriatr, Nantong 226011, Peoples R China
[2] Shanghai Univ, Shanghai Engn Res Ctr Organ Repair, Sch Life Sci, Shanghai 200444, Peoples R China
[3] Hannover Med Sch, Inst Mol & Translat Therapeut Strategies, D-30625 Hannover, Germany
[4] Hannover Med Sch, REBIRTH Ctr Translat Regenerat Med, D-30625 Hannover, Germany
[5] Witten Herdecke Univ, Fac Hlth Sch Med, D-58448 Witten, Germany
[6] Tongji Univ, Tongji Hosp, Dept Cardiol, Sch Med, Shanghai 200065, Peoples R China
[7] Xuzhou Med Univ, Affiliated Hosp 2, Dept Cardiothorac Surg, Xuzhou 221002, Jiangsu, Peoples R China
[8] Fraunhofer Inst Toxicol & Expt Med, D-30625 Hannover, Germany
基金
中国国家自然科学基金;
关键词
ISCHEMIA-REPERFUSION INJURY; NONCODING RNAS; GROWTH; CELLS; APOPTOSIS; SURVIVAL; DISEASE; PTEN; AKT;
D O I
10.1016/j.ymthe.2022.01.031
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Exercise and its regulated molecules have myocardial protective effects against cardiac ischemia/reperfusion (I/R) injury. The muscle-enriched miR-486 was previously identified to be upregulated in the exercised heart, which prompted us to investigate the functional roles of miR-486 in cardiac I/R injury and to further explore its potential in contributing to exercise-induced protection against I/R injury. Our data showed that miR-486 was significantly downregulated in the heart upon cardiac I/R injury. Both preventive and therapeutic interventions of adeno-associated virus 9 (AAV9)-mediated miR-486 overexpression could reduce cardiac I/R injury. Using AAV9 expressing miR-486 with a cTnT promoter, we further demonstrated that cardiac muscle cell-targeted miR-486 overexpression was also sufficient to protect against cardiac I/R injury. Consistently, miR-486 was downregulated in oxygen-glucose deprivation/reperfusion (OGDR)-stressed cardiomyocytes, while upregulating miR-486 inhibited cardiomyocyte apoptosis through PTEN and FoxO1 inhibition and AKT/mTOR activation. Finally, we observed that miR-486 was necessary for exercise-induced protection against cardiac I/R injury. In conclusion, miR-486 is protective against cardiac I/R injury and myocardial apoptosis through targeting of PTEN and FoxO1 and activation of the AKT/mTOR pathway, and mediates the beneficial effect of exercise for myocardial protection. Increasing miR-486 might be a promising therapeutic strategy for myocardial protection.
引用
收藏
页码:1675 / 1691
页数:17
相关论文
共 50 条
  • [1] miR-486 Mediates the Benefits of Exercise in Attenuating Cardiac Fibrosis
    Lv, Dongchao
    Bei, Yihua
    Zhou, Qiulian
    Sun, Qi
    Xu, Tianzhao
    Xiao, Junjie
    CIRCULATION RESEARCH, 2015, 117
  • [2] Cardiac Ischemia/Reperfusion Injury: The Beneficial Effects of Exercise
    Borges, Juliana Pereira
    Verdoorn, Karine da Silva
    EXERCISE FOR CARDIOVASCULAR DISEASE PREVENTION AND TREATMENT: FROM MOLECULAR TO CLINICAL, PT 1, 2017, 999 : 155 - 179
  • [3] microRNA-486 mediates exercise-induced cardiac growth and prevents cardiac ischemia-reperfusion injury
    Bei, Y.
    Lu, D.
    Meng, X.
    Zhu, Y.
    Liang, X.
    Xiao, J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3287 - 3287
  • [4] Cardiac Microvascular Barrier Function Mediates the Protection of Tongxinluo against Myocardial Ischemia/Reperfusion Injury
    Qi, Kang
    Li, Lujin
    Li, Xiangdong
    Zhao, Jinglin
    Wang, Yang
    You, Shijie
    Hu, Fenghuan
    Zhang, Haitao
    Cheng, Yutong
    Kang, Sheng
    Cui, Hehe
    Duan, Lian
    Jin, Chen
    Zheng, Qingshan
    Yang, Yuejin
    PLOS ONE, 2015, 10 (03):
  • [5] Endothelial protection attenuates ischemia reperfusion injury in transplantation and myocardial infarction
    Rieben, Robert
    JOURNAL OF VASCULAR RESEARCH, 2009, 46 : 30 - 30
  • [6] Exercise-Induced miR-210 Promotes Cardiomyocyte Proliferation and Survival and Mediates Exercise-Induced Cardiac Protection against Ischemia/Reperfusion Injury
    Bei, Yihua
    Wang, Hongyun
    Liu, Yang
    Su, Zhuhua
    Li, Xinpeng
    Zhu, Yujiao
    Zhang, Ziyi
    Yin, Mingming
    Chen, Chen
    Li, Lin
    Wei, Meng
    Meng, Xiangmin
    Liang, Xuchun
    Huang, Zhenzhen
    Cao, Richard Yang
    Wang, Lei
    Li, Guoping
    Cretoiu, Dragos
    Xiao, Junjie
    RESEARCH, 2024, 7
  • [7] Beneficial effect of exogenous nitric oxide in myocardial ischemia/reperfusion injury
    Bruegger, D
    Jacob, M
    Rehm, M
    Becker, BF
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (06) : 1004 - 1004
  • [8] Translational control of the myocardial inflammatory response mediates cardiac ischemia/reperfusion injury
    Hofmann, Christoph
    Serafin, Adrian
    Schwerdt, Ole M.
    Sicklinger, Florian
    Younesi, Fereshteh S.
    Meyer, Ingmar S.
    Malovrh, Ellen
    Sandmann, Clara
    Juergensen, Lonny
    Kamuf-Schenk, Verena
    Stroh, Claudia
    Katus, Hugo
    Frey, Norbert
    Leuschner, Florian
    Voelkers, Mirko
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022, 173 : S124 - S124
  • [9] Interleukin-6 mediates exercise preconditioning against myocardial ischemia reperfusion injury
    McGinnis, Graham Ripley
    Ballmann, Christopher
    Peters, Bridget
    Nanayakkara, Gayani
    Roberts, Michael
    Amin, Rajesh
    Quindry, John C.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2015, 308 (11): : H1423 - H1433
  • [10] Clarithromycin attenuates myocardial ischemia-reperfusion injury
    Nakajima, Takuya
    Hishikari, Keiichi
    Ogawa, Masahito
    Watanabe, Ryo
    Suzuki, Jun-ichi
    Nagashima, Ayako
    Masumura, Mayumi
    Takayama, Kiyoshi
    Hirata, Yasunobu
    Nagai, Ryozo
    Isobe, Mitsuaki
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (09) : 881 - 893